Phenome-wide Mendelian randomization study of plasma triglyceride levels and 2600 disease traits

Abstract
Background: Causality between plasma triglyceride (TG) levels and atherosclerotic cardiovascular disease (ASCVD) risk remains controversial despite more than four decades of study and two recent landmark trials, STRENGTH and REDUCE-IT. Further unclear is the association between TG levels and non-atherosclerotic diseases across organ systems.
Funding Information
  • National Institute of General Medical Sciences (R35-GM124836)
  • National Heart, Lung, and Blood Institute (R01-HL139865)
  • National Heart, Lung, and Blood Institute (R01-HL155915)